...
首页> 外文期刊>Expert review of cardiovascular therapy >Percutaneous treatment of left main and non-left main bifurcation coronary lesions using drug-eluting stents.
【24h】

Percutaneous treatment of left main and non-left main bifurcation coronary lesions using drug-eluting stents.

机译:使用药物洗脱支架对左主干和非左主干分叉冠状动脉病变进行经皮治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

Current evidence and guidelines support the use of the single-stent technique as the default treatment strategy for the treatment of coronary bifurcations. For the single-stent technique, routine final kissing balloon inflation is not recommended, unless side branch ostial stenosis is assumed to be functionally significant. The double-stent technique is still a viable option for bifurcations with large and severely diseased side branches. Due to the unique features of bifurcation anatomy and bifurcation stenting techniques, all deployed stents should be optimized by postdilation, kissing balloon inflation and/or the proximal optimization technique, regardless of the stenting technique used. Intravascular ultrasound can guide preimplantation decision-making and postimplantation optimization by providing information on reference diameter, plaque burden and distribution, and stent underexpansion and malapposition.
机译:当前的证据和指南支持使用单支架技术作为冠状动脉分叉治疗的默认治疗策略。对于单支架技术,不建议常规的最终接吻球囊充气,除非假定侧支小动脉狭窄在功能上很重要。对于具有大而严重患病的侧支的分叉,双支架技术仍然是可行的选择。由于分叉解剖学和分叉支架技术的独特特征,无论使用何种支架技术,都应通过后扩张,接吻球囊扩张和/或近端优化技术来优化所有已部署的支架。血管内超声可通过提供有关参考直径,斑块负荷和分布以及支架扩张不足和贴壁不良的信息,指导植入前决策和植入后优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号